Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan
· Delayed Price · Currency is TWD 16.90
+1.05 (6.62%)
Mar 10, 2026, 12:36 PM CST
Original BioMedicals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 107.9 | 151.45 | 228.68 | 13.98 | 8.46 | 8.1 | Upgrade
|
| Short-Term Investments | 89.83 | 89.74 | 99.8 | 34.93 | 74.85 | - | Upgrade
|
| Cash & Short-Term Investments | 197.73 | 241.19 | 328.48 | 48.91 | 83.31 | 8.1 | Upgrade
|
| Cash Growth | -29.82% | -26.57% | 571.60% | -41.29% | 928.77% | -64.51% | Upgrade
|
| Accounts Receivable | 0.2 | - | - | - | - | - | Upgrade
|
| Other Receivables | 13.51 | 13.51 | 11.55 | 9.99 | 9.59 | 8.91 | Upgrade
|
| Receivables | 13.71 | 13.51 | 11.55 | 9.99 | 9.59 | 8.91 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.71 | Upgrade
|
| Other Current Assets | 2.95 | 1.61 | 1.37 | 0.89 | 1.55 | 0.09 | Upgrade
|
| Total Current Assets | 214.39 | 256.31 | 341.4 | 59.79 | 94.46 | 17.8 | Upgrade
|
| Property, Plant & Equipment | 18 | 21.9 | 28.08 | 36.19 | 41.03 | 47.72 | Upgrade
|
| Other Long-Term Assets | 1.16 | 1.16 | 1.16 | 2.05 | 1.88 | 1.88 | Upgrade
|
| Total Assets | 233.55 | 279.37 | 370.63 | 98.04 | 137.37 | 67.4 | Upgrade
|
| Accrued Expenses | 8.76 | 6.76 | 7.48 | 4.29 | 3.93 | 2.31 | Upgrade
|
| Current Portion of Leases | 4.62 | 4.52 | 4.26 | 3.62 | 3.14 | 2.95 | Upgrade
|
| Other Current Liabilities | 2.44 | 3.15 | 18.12 | 2.46 | 1.44 | 1.29 | Upgrade
|
| Total Current Liabilities | 15.83 | 14.43 | 29.86 | 10.36 | 8.52 | 6.55 | Upgrade
|
| Long-Term Leases | 5.14 | 7.47 | 11.98 | 16.27 | 17.52 | 20.66 | Upgrade
|
| Other Long-Term Liabilities | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | Upgrade
|
| Total Liabilities | 23.19 | 24.12 | 44.07 | 28.86 | 28.26 | 29.44 | Upgrade
|
| Common Stock | 663.51 | 659.92 | 655.5 | 470.5 | 470.5 | 287 | Upgrade
|
| Additional Paid-In Capital | 1.32 | 384.17 | 384.9 | 252.85 | 252.51 | 330.99 | Upgrade
|
| Retained Earnings | -454.7 | -788.83 | -713.84 | -654.18 | -613.9 | -580.02 | Upgrade
|
| Comprehensive Income & Other | 0.24 | - | - | - | - | - | Upgrade
|
| Shareholders' Equity | 210.37 | 255.25 | 326.57 | 69.17 | 109.11 | 37.97 | Upgrade
|
| Total Liabilities & Equity | 233.55 | 279.37 | 370.63 | 98.04 | 137.37 | 67.4 | Upgrade
|
| Total Debt | 9.76 | 11.98 | 16.24 | 19.89 | 20.66 | 23.61 | Upgrade
|
| Net Cash (Debt) | 187.97 | 229.21 | 312.24 | 29.02 | 62.65 | -15.52 | Upgrade
|
| Net Cash Growth | -29.76% | -26.59% | 976.08% | -53.69% | - | - | Upgrade
|
| Net Cash Per Share | 2.83 | 3.47 | 6.33 | 0.62 | 1.51 | -0.56 | Upgrade
|
| Filing Date Shares Outstanding | 66.35 | 65.99 | 65.55 | 47.05 | 47.05 | 28.7 | Upgrade
|
| Total Common Shares Outstanding | 66.35 | 65.99 | 65.55 | 47.05 | 47.05 | 28.7 | Upgrade
|
| Working Capital | 198.56 | 241.88 | 311.54 | 49.43 | 85.94 | 11.25 | Upgrade
|
| Book Value Per Share | 3.17 | 3.87 | 4.98 | 1.47 | 2.32 | 1.32 | Upgrade
|
| Tangible Book Value | 210.37 | 255.25 | 326.57 | 69.17 | 109.11 | 37.97 | Upgrade
|
| Tangible Book Value Per Share | 3.17 | 3.87 | 4.98 | 1.47 | 2.32 | 1.32 | Upgrade
|
| Machinery | 45.05 | 44.92 | 47.15 | 46.96 | 46.84 | 44.92 | Upgrade
|
| Leasehold Improvements | 36.85 | 36.85 | 36.85 | 36.73 | 36.38 | 36.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.